Literature DB >> 20458273

CCN1 induces a reversible epithelial-mesenchymal transition in gastric epithelial cells.

Jianyuan Chai1, Manith Norng, Cristina Modak, Kevin M Reavis, Wasim Mouazzen, Jennifer Pham.   

Abstract

CCN1 is a matricellular protein that activates many genes related to wound healing and tissue remodeling in fibroblasts, but its effect on epithelial cells remains unclear. This study examined the role of CCN1 in epithelial wound healing using rat gastric epithelial cells and rat stomach ulcer as in vitro and in vivo models, respectively. We found that CCN1 expression is highly upregulated in the epithelial cells adjacent to a wound and remains high until the wound is healed. Upregulation of CCN1 activates a transient epithelial-mesenchymal transition in the epithelial cells at the migrating front and drives wound closure. Once the wound is healed, these epithelial cells and their progeny can resume their original epithelial phenotype. We also found that CCN1-induced E-cadherin loss is not due to transcriptional regulation but rather protein degradation due to the collapse of adherens junctions, which is contributed by beta-catenin translocation. CCN1-activated integrin-linked kinase mediates this process. Finally, our in vivo study showed that locally neutralizing CCN1 drastically impairs wound closure, whereas local injection of recombinant CCN1 protein induces expression of vimentin and smooth muscle alpha-actin in normal gastric mucosal epithelial cells and accelerates re-epithelialization during ulcer healing. In conclusion, our study indicates that CCN1 can induce reversible epithelial-mesenchymal transition, and this feature may have great value for clinical wound healing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458273     DOI: 10.1038/labinvest.2010.101

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Cell behavior on a CCN1 functionalized elastin-mimetic protein polymer.

Authors:  Swathi Ravi; Carolyn A Haller; Rory E Sallach; Elliot L Chaikof
Journal:  Biomaterials       Date:  2011-12-31       Impact factor: 12.479

2.  S100A4 in esophageal cancer: is this the one to blame?

Authors:  Jianyuan Chai; M Mazen Jamal
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

3.  Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis.

Authors:  Inamul Haque; Smita Mehta; Monami Majumder; Kakali Dhar; Archana De; Douglas McGregor; Peter J Van Veldhuizen; Sushanta K Banerjee; Snigdha Banerjee
Journal:  Mol Cancer       Date:  2011-01-13       Impact factor: 27.401

4.  Pathway-based evaluation in early onset colorectal cancer suggests focal adhesion and immunosuppression along with epithelial-mesenchymal transition.

Authors:  Seungyoon Nam; Taesung Park
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

5.  CCN1 Induces β-Catenin Translocation in Esophageal Squamous Cell Carcinoma through Integrin α11.

Authors:  Jianyuan Chai; Cristina Modak; Yi Ouyang; Sing-Yung Wu; M Mazen Jamal
Journal:  ISRN Gastroenterol       Date:  2012-05-31

6.  IGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion.

Authors:  Suren Sarkissyan; Marianna Sarkissyan; Yanyuan Wu; Jessica Cardenas; H Phillip Koeffler; Jaydutt V Vadgama
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

7.  The CCN1 (CYR61) protein promotes skin growth by enhancing epithelial-mesenchymal transition during skin expansion.

Authors:  Yiwen Zhou; Haizhou Li; Xiao Liang; Hengyu Du; Yingjun Suo; Hao Chen; Wenhui Liu; Ran Duan; Xiaolu Huang; Qingfeng Li
Journal:  J Cell Mol Med       Date:  2019-12-11       Impact factor: 5.310

Review 8.  The Roles of CCN1/CYR61 in Pulmonary Diseases.

Authors:  Yin Zhu; Sultan Almuntashiri; Yohan Han; Xiaoyun Wang; Payaningal R Somanath; Duo Zhang
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.